How much is the Sarcoidosis Therapeutics Market market?

The sarcoidosis therapeutics market market size is estimated to grow at $$ 72.82 mn in 2023. Read More

What is the growth rate of the Sarcoidosis Therapeutics Market market?

The growth rate of the sarcoidosis therapeutics market year-over-year is 4.94%. Read More

Which region held the largest market share in the Sarcoidosis Therapeutics Market market?

North America is the region to held the largest market share with 35% growth. Read More

Who are the key players in the Sarcoidosis Therapeutics Market market?

AbbVie Inc., Amneal Pharmaceuticals Inc., Anant Pharmaceuticals Pvt. Ltd., Atom Pharma, aTyr Pharma Inc., Fresenius SE and Co. KGaA, Halozyme Therapeutics Inc., Horizon Therapeutics Plc, .... Read More

Which Segment has the largest market share in the Sarcoidosis Therapeutics Market market?

Product is the segment that has the largest market share in the market. Read More

Sarcoidosis Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Dec 2023
Pages: 158
SKU: IRTNTR72397

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global sarcoidosis therapeutics market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global sarcoidosis therapeutics market 2018 - 2022 ($ million)

4.2 Product Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ million)

4.3 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product - Market share 2023-2028 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 Corticosteroids - Market size and forecast 2023-2028
- Exhibit 34: Chart on Corticosteroids - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)

6.4 Immunosuppressants and others - Market size and forecast 2023-2028
- Exhibit 38: Chart on Immunosuppressants and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Immunosuppressants and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Immunosuppressants and others - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Immunosuppressants and others - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
- Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)

7.2 Comparison by Distribution Channel
- Exhibit 46: Chart on Comparison by Distribution Channel
- Exhibit 47: Data Table on Comparison by Distribution Channel

7.3 Hospital pharmacy - Market size and forecast 2023-2028
- Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)

7.4 Retail pharmacy - Market size and forecast 2023-2028
- Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)

7.5 Online pharmacy - Market size and forecast 2023-2028
- Exhibit 56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Distribution Channel
- Exhibit 60: Market opportunity by Distribution Channel ($ million)
- Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 AbbVie Inc.
- Exhibit 111: AbbVie Inc. - Overview
- Exhibit 112: AbbVie Inc. - Product / Service
- Exhibit 113: AbbVie Inc. - Key news
- Exhibit 114: AbbVie Inc. - Key offerings

12.4 Amneal Pharmaceuticals Inc.
- Exhibit 115: Amneal Pharmaceuticals Inc. - Overview
- Exhibit 116: Amneal Pharmaceuticals Inc. - Business segments
- Exhibit 117: Amneal Pharmaceuticals Inc. - Key news
- Exhibit 118: Amneal Pharmaceuticals Inc. - Key offerings
- Exhibit 119: Amneal Pharmaceuticals Inc. - Segment focus

12.5 Anant Pharmaceuticals Pvt. Ltd.
- Exhibit 120: Anant Pharmaceuticals Pvt. Ltd. - Overview
- Exhibit 121: Anant Pharmaceuticals Pvt. Ltd. - Product / Service
- Exhibit 122: Anant Pharmaceuticals Pvt. Ltd. - Key offerings

12.6 aTyr Pharma Inc.
- Exhibit 123: aTyr Pharma Inc. - Overview
- Exhibit 124: aTyr Pharma Inc. - Product / Service
- Exhibit 125: aTyr Pharma Inc. - Key offerings

12.7 Fresenius SE and Co. KGaA
- Exhibit 126: Fresenius SE and Co. KGaA - Overview
- Exhibit 127: Fresenius SE and Co. KGaA - Business segments
- Exhibit 128: Fresenius SE and Co. KGaA - Key news
- Exhibit 129: Fresenius SE and Co. KGaA - Key offerings
- Exhibit 130: Fresenius SE and Co. KGaA - Segment focus

12.8 Halozyme Therapeutics Inc.
- Exhibit 131: Halozyme Therapeutics Inc. - Overview
- Exhibit 132: Halozyme Therapeutics Inc. - Product / Service
- Exhibit 133: Halozyme Therapeutics Inc. - Key offerings

12.9 Horizon Therapeutics Plc
- Exhibit 134: Horizon Therapeutics Plc - Overview
- Exhibit 135: Horizon Therapeutics Plc - Business segments
- Exhibit 136: Horizon Therapeutics Plc - Key news
- Exhibit 137: Horizon Therapeutics Plc - Key offerings
- Exhibit 138: Horizon Therapeutics Plc - Segment focus

12.10 Mallinckrodt Plc
- Exhibit 139: Mallinckrodt Plc - Overview
- Exhibit 140: Mallinckrodt Plc - Business segments
- Exhibit 141: Mallinckrodt Plc - Key offerings
- Exhibit 142: Mallinckrodt Plc - Segment focus

12.11 Novartis AG
- Exhibit 143: Novartis AG - Overview
- Exhibit 144: Novartis AG - Business segments
- Exhibit 145: Novartis AG - Key offerings
- Exhibit 146: Novartis AG - Segment focus

12.12 Pfizer Inc.
- Exhibit 147: Pfizer Inc. - Overview
- Exhibit 148: Pfizer Inc. - Product / Service
- Exhibit 149: Pfizer Inc. - Key news
- Exhibit 150: Pfizer Inc. - Key offerings

12.13 Prometheus Laboratories
- Exhibit 151: Prometheus Laboratories - Overview
- Exhibit 152: Prometheus Laboratories - Product / Service
- Exhibit 153: Prometheus Laboratories - Key offerings

12.14 RELIEF THERAPEUTICS Holding SA
- Exhibit 154: RELIEF THERAPEUTICS Holding SA - Overview
- Exhibit 155: RELIEF THERAPEUTICS Holding SA - Product / Service
- Exhibit 156: RELIEF THERAPEUTICS Holding SA - Key offerings

12.15 Teva Pharmaceutical Industries Ltd.
- Exhibit 157: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 158: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 161: Teva Pharmaceutical Industries Ltd. - Segment focus

12.16 Viatris Inc.
- Exhibit 162: Viatris Inc. - Overview
- Exhibit 163: Viatris Inc. - Business segments
- Exhibit 164: Viatris Inc. - Key news
- Exhibit 165: Viatris Inc. - Key offerings
- Exhibit 166: Viatris Inc. - Segment focus

12.17 Xentria Inc.
- Exhibit 167: Xentria Inc. - Overview
- Exhibit 168: Xentria Inc. - Product / Service
- Exhibit 169: Xentria Inc. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 170: Inclusions checklist
- Exhibit 171: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 172: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 173: Research methodology
- Exhibit 174: Validation techniques employed for market sizing
- Exhibit 175: Information sources

13.5 List of abbreviations
- Exhibit 176: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES